Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Pacher

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 21, 2004
Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failureMarianne Gwechenberger, Martin Hülsmann, Rudolf Berger, et al.
European Journal of Internal Medicine|July 20, 2011
Benefit of specialized clinics for the treatment of patients with heart failureGhazaleh Gouya, Alexandra Hammer, Marie Elhenicky, et al.
European Journal of Heart Failure|February 23, 2013
Renal function in heart failure: a disparity between estimating function and predicting mortality riskMax Plischke, Stephanie Neuhold, Maria Kohl, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 23, 2003
Sequential big endothelin plasma levels in heart transplant recipients during bridging therapy and after successful heart transplantationJeanette Strametz-Juranek, Richard Pacher, Thomas Kos, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 20, 2002
Intimal hyperplasia and coronary flow reserve after heart transplantation: association with big endothelin-1Paul Wexberg, Richard Pacher, Suzanne Rödler, et al.
European Journal of Preventive Cardiology|April 1, 2011
NT-proBNP as a means of triage for the risk of hospitalisation in primary careChristopher Adlbrecht, Stephanie Neuhold, Martin Hülsmann, et al.
Journal of the American College of Cardiology|February 23, 2010
N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot studyRudolf Berger, Deddo Moertl, Sieglinde Peter, et al.
Journal of the American College of Cardiology|September 20, 2005
Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptideBrigitte Meyer, Deddo Mörtl, Karin Strecker, et al.
Pathology, Research and Practice|June 19, 2003
Revascularization of myocardial scar tissue following prostaglandin E1-therapy in patients with ischemic heart diseaseMohammad Reza Mehrabi, Nermin Serbecic, Forouzan Tamaddon, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 6, 2003
Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation periodRudolf Berger, Karin Strecker, Martin Huelsmann, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 21, 2004
Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failureMarianne Gwechenberger, Martin Hülsmann, Rudolf Berger, et al.
European Journal of Internal Medicine|July 20, 2011
Benefit of specialized clinics for the treatment of patients with heart failureGhazaleh Gouya, Alexandra Hammer, Marie Elhenicky, et al.
European Journal of Heart Failure|February 23, 2013
Renal function in heart failure: a disparity between estimating function and predicting mortality riskMax Plischke, Stephanie Neuhold, Maria Kohl, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 23, 2003
Sequential big endothelin plasma levels in heart transplant recipients during bridging therapy and after successful heart transplantationJeanette Strametz-Juranek, Richard Pacher, Thomas Kos, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 20, 2002
Intimal hyperplasia and coronary flow reserve after heart transplantation: association with big endothelin-1Paul Wexberg, Richard Pacher, Suzanne Rödler, et al.
European Journal of Preventive Cardiology|April 1, 2011
NT-proBNP as a means of triage for the risk of hospitalisation in primary careChristopher Adlbrecht, Stephanie Neuhold, Martin Hülsmann, et al.
Journal of the American College of Cardiology|February 23, 2010
N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot studyRudolf Berger, Deddo Moertl, Sieglinde Peter, et al.
Journal of the American College of Cardiology|September 20, 2005
Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptideBrigitte Meyer, Deddo Mörtl, Karin Strecker, et al.
Pathology, Research and Practice|June 19, 2003
Revascularization of myocardial scar tissue following prostaglandin E1-therapy in patients with ischemic heart diseaseMohammad Reza Mehrabi, Nermin Serbecic, Forouzan Tamaddon, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 6, 2003
Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation periodRudolf Berger, Karin Strecker, Martin Huelsmann, et al.
Pageof 9